In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study (Q72030910)
Jump to navigation
Jump to search
scientific article published on September 15, 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study |
scientific article published on September 15, 1995 |
Statements
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study (English)
Broxmeyer HE
Williams DE
S. Vadhan-Raj
M. Andreeff
J. C. Bandres
E. S. Buescher
R. S. Benjamin
N. E. Papadopoulos
A. Burgess
S. Patel
C. Plager
W. N. Hittelman
I. McAlister
1 September 1995